SIROMED PHARMA, UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
10,324,000 |
690,107 |
209,000 |
174,000 |
11,631 |
14.61 |
1.69 |
1,163,000 |
5,136,000 |
203,000 |
6,096,000 |
2022 |
---|
11,745,000 |
821,329 |
218,000 |
178,000 |
12,448 |
14.99 |
1.52 |
1,341,000 |
5,526,000 |
171,000 |
6,696,000 |
2023 |
---|
11,011,000 |
799,637 |
33,000 |
5,000 |
363 |
15.09 |
0.05 |
1,346,000 |
6,104,000 |
147,000 |
7,303,000 |
Register and
explore Okredo data2023 |
---|
11,011,000 |
799,637 |
33,000 |
5,000 |
363 |
15.09 |
0.05 |
1,346,000 |
6,104,000 |
147,000 |
7,303,000 |
Register and
explore Okredo data2023
Turnover (€)
11,011,000 €-6 % *
Sales per employee (€)
799,637 €-3 % *
Profit before tax (€)
33,000 €-85 % *
Net Profit (€)
5,000 €-97 % *
Profit per employee (€)
363 €-97 % *
Total profitability (%)
15.09 %0.67 % *
Net profitability (%)
0.05 %-96.71 % *
Equity (€)
1,346,000 €0 % *
Amounts Payable And Liabilities (€)
6,104,000 €10 % *
Non-current Assets (€)
147,000 €-14 % *
CurrentAssets (€)
7,303,000 €9 % *